The EU life sciences sector is buzzing with growth. Across the industry, sales and marketing teams are expanding at an impressive pace up 18% and it’s easy to see why. Start-ups, especially those in Series B and C, are attracting significant investment, and companies are increasingly taking bold steps to bring their products to market.
AI is at the heart of this transformation. From streamlining go-to-market strategies to helping teams launch products more efficiently, technology is enabling innovation at a speed we haven’t seen before. Biotech firms, once focused solely on research, are now stepping into commercial roles themselves, creating a real demand for professionals who can navigate sales strategies across multiple territories.
Medtech is riding a similar wave. The combination of an aging population, remote monitoring, home-based care, and AI-driven healthcare solutions is creating a surge in commercial roles. From product trainers to sales specialists and clinical application experts, companies are looking for talent that can help them bring innovative solutions to market.
The investment landscape is shaping hiring patterns too. More drug launches, especially in the biosimilars space, are driving recruitment, while weaker seed-stage funding is encouraging strategic outsourcing to minimise risk. And with US regulations and tariffs prompting non-US companies to explore the EU, new opportunities are opening up across the region.
The message is clear: the EU life sciences industry is evolving fast. Companies that embrace AI-driven commercialisation and invest in the right talent are positioning themselves for success and for professionals in sales, marketing, and product strategy, it’s an exciting time to be part of the journey.